Clinical Trial Update: Compare the Efficacy and Safety of Dec-FB4 and FB4 as Conditioning Regimen for AML-MR [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is planned to compare Dec-FB4 and FB4 as conditioning regimens for acute myeloid leukemia with myelodysplasia-related changes (AML-MR);…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia with Myelodysplasia-related Changes

Drugs mentioned

• Dec-FB4
• FB4

Snippet

Sponsor: Ruijin Hospital | Conditions: AML, Adult | Phase 3 | Status: NOT_YET_RECRUITING